Analyst Reco. Merck & Co., Inc.

Equities

MRK

US58933Y1055

Market Closed - Nyse Other stock markets 01:30:02 13/09/2024 am IST			5-day change	1st Jan Change
115.25 ^USD	+0.47%		-2.82%	+5.71%

12/09	Merck Says Health Canada Approved Keytruda as Treatment for Hard-to-Treat Solid Tumors	MT
11/09	Merck: positive results for HPV vaccine	CF

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Citic Securities Initiates Merck & Co. at Buy With $136 Price Target	29/08	MT
Jefferies Adjusts Merck & Company Price Target to $147 From $150	15/08	MT
Deutsche Bank Adjusts Price Target on Merck to $145 From $140	08/08	MT
Berenberg Adjusts Price Target on Merck & Co. to $135 From $143, Maintains Buy Rating	08/08	MT
Daiwa Securities Adjusts Merck & Company Price Target to $130 From $150, Maintains Outperform Rating	06/08	MT
UBS Adjusts Merck & Co.'s Price Target to $142 From $148, Maintains Buy Rating	31/07	MT
Morgan Stanley Adjusts Price Target on Merck & Company to $130 From $134	31/07	MT
Goldman Sachs Adjusts Price Target on Merck & Company to $140 From $145, Maintains Buy Rating	31/07	MT
Guggenheim Adjusts Price Target on Merck & Company to $138 From $142, Maintains Buy Rating	31/07	MT
Wolfe Research Adjusts Price Target on Merck & Co. to $142 From $151, Maintains Outperform Rating	31/07	MT
Barclays Adjusts Price Target on Merck & Co. to $142 From $145, Maintains Overweight Rating	31/07	MT
Wells Fargo Adjusts Price Target on Merck & Co. to $125 From $140, Maintains Equalweight Rating	31/07	MT
BMO Capital Adjusts Price Target on Merck to $150 From $148	19/07	MT
TD Cowen Adjusts Price Target on Merck to $140 From $135	17/07	MT
Goldman Sachs Adjusts Price Target on Merck & Company to $145 From $144	16/07	MT
Morgan Stanley Adjusts Price Target on Merck to $134 From $132	11/07	MT
HSBC Adjusts Price Target on Merck & Co. to $130 From $118, Keeps Hold Rating	05/06	MT
Analyst recommendations: Boeing, Dell, Merck, RyanAir...	27/05
Redburn Atlantic Adjusts Price Target on Merck to $148 From $142	01/05	MT
Wolfe Research Adjusts Price Target on Merck & Company to $151 From $141	26/04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Merck & Co., Inc.

Equities

MRK

US58933Y1055

Analyst Reco.

Filters